ADD/ADHD News

ORLANDO, Fla. — Strategies shown to decrease intestinal and blood-brain barrier permeability — like probiotics, prebiotics and supplements such as fish oil — may help subgroups of patients with depression and other psychiatric disorders, according to a presenter here.

Electroencephalography, or EEG, technology that measures brain function could encourage earlier diagnoses of common mental and neurological disorders, including autism, ADHD and dementia, according to findings published in The Neurodiagnostic Journal.

Patients with ADHD who were treated with amphetamine- or methylphenidate-based medications may be at higher risk for basal ganglia and cerebellum disorders such as Parkinson’s disease, secondary parkinsonism or essential tremor later in life, according to findings recently published in Neuropsychopharmacology.

Using data from a multi-institutional survey of college students in the United States, researchers at Ohio State University found that nearly 16% of students reported misusing prescription stimulants.

The prevalence of ADHD medication use has increased over time among adults and children between 2001 and 2015, according study data involving more than 154 million people from 14 countries published in The Lancet Psychiatry.

The estimated prevalence of diagnosed ADHD in U.S. children and adolescents increased significantly in the last 2 decades, according to study results published in JAMA Network Open.

Children who lived in households with adults who smoked or were depressed demonstrated a significant increase in ADHD prevalence, according to findings recently published in Asia-Pacific Psychiatry.

Athletes with ADHD have a greater risk for anxiety and depression after a concussion, according to a study presented at the American Academy of Neurology’s Sports Concussion Conference.

Study findings published in Biological Psychiatry showed that youth with history of traumatic brain injury reported greater ADHD symptom severity than those without injury.

Methylphenidate for children and amphetamines for adults were the preferred first-choice medications for the short-term treatment of ADHD, according to results from a network meta-analysis and systematic review.